Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cleocin Phosphate
2. Clindamycin-2-phosphate
3. Clindesse
4. Clindets
1. 24729-96-2
2. Cleocin Phosphate
3. Clindamycin 2-phosphate
4. Clindets
5. Cleocin T
6. Clindagel
7. Clindesse
8. Evoclin
9. Clinda-derm
10. Dalacin P
11. Clindamycin-2-phosphate
12. Clindamycin 2-dihydrogen Phosphate
13. Clindamycin (phosphate)
14. Dalacin T
15. 7(s)-chloro-7-deoxylincomycin 2-phosphate
16. U 28508
17. U-28508
18. U-28,508
19. Eh6d7113i8
20. Nsc 618653
21. Nsc-618653
22. Dsstox_cid_28603
23. Dsstox_rid_82873
24. Dsstox_gsid_48677
25. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] Dihydrogen Phosphate
26. Clindamax
27. Evoclin (tn)
28. Dalacin-s (tn)
29. Clindamycin Injection
30. Cas-24729-96-2
31. Einecs 246-433-0
32. Clindamycin Phosphate Hydrate [jan]
33. Clindamycin Dihydrogenphosphat
34. Clinadac
35. Unii-eh6d7113i8
36. Clindamycin Phosphate Hydrate
37. Clindamycin Phosphate In Dextrose 5%
38. Clindamycin-2-dihydrogenphosphat
39. Ncgc00163494-01
40. Ncgc00166320-01
41. Clindamycin-phosphate
42. Clindac
43. Xaciato
44. Clindamycin Phosphate [usan:usp:jan]
45. Cleocin Phosphate In Dextrose 5% In Plastic Container
46. Clindamycin Phosphate In Dextrose 5% In Plastic Container
47. Schembl37148
48. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
49. Chembl3184512
50. Dtxsid1048677
51. Bdbm241975
52. Clindamycin (as Phosphate)
53. Clindamycin Phosphate (jp17/usp)
54. Clindamycin Phosphate [jan]
55. Hy-b1064
56. Zinc4102185
57. Clindamycin Phosphate [usan]
58. Tox21_113055
59. Tox21_113410
60. Clindamycin Phosphate (u-28508e)
61. Clindamycin Phosphate [vandf]
62. Mfcd11982855
63. S2048
64. Clindamycin Phosphate [mart.]
65. Akos008901431
66. Clindamycin Phosphate [usp-rs]
67. Clindamycin Phosphate [who-dd]
68. Clindamycin Phosphate [who-ip]
69. Ccg-269736
70. Clindamycin Phosphate System Suitability
71. Cs-4620
72. Ncgc00386379-01
73. As-12554
74. L-threo-alpha-d-galacto-octapyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate), (2s-trans)-
75. Methyl (2s-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-l-threo-alpha-d-galacto-octopyranoside, 2-(dihydrogen Phosphate)
76. Clindamycin Phosphate [orange Book]
77. Duac Component Clindamycin Phosphate
78. Clindamycin Phosphate [ep Monograph]
79. Clindamycin Phosphate For System Suitability
80. Ziana Component Clindamycin Phosphate
81. Acanya Component Clindamycin Phosphate
82. Clindamycin Phosphate [usp Monograph]
83. Clindamycini Phosphas [who-ip Latin]
84. Veltin Component Clindamycin Phosphate
85. Clindamycin Phosphate Component Of Duac
86. Benzaclin Component Clindamycin Phosphate
87. Clindamycin 2-dihydrogen Phosphate [mi]
88. Clindamycin Phosphate Component Of Ziana
89. D01073
90. Idp-126 Component Clindamycin Phosphate
91. Ab01566857_01
92. Clindamycin Phosphate Component Of Acanya
93. Clindamycin Phosphate Component Of Veltin
94. A817470
95. Clindamycin Phosphate Component Of Benzaclin
96. Sr-01000872581
97. Sr-01000872581-1
98. Brd-k27771035-001-02-5
99. Q27106184
100. Clindamycin Phosphate System Suitability [usp-rs]
101. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl Dihydrogen Phosphate
102. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yldihydrogenphosphate
103. (2s-trans)-methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
104. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] Dihydrogen Phosphate
105. [(2r,4r,5r)-6-[(2s)-2-chloro-1-[[[(2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl]-oxomethyl]amino]propyl]-4,5-dihydroxy-2-(methylthio)-3-oxanyl] Dihydrogen Phosphate
106. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-((((2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate)
107. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate), (2s-trans)-
108. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
| Molecular Weight | 505.0 g/mol |
|---|---|
| Molecular Formula | C18H34ClN2O8PS |
| XLogP3 | -1.2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 504.1462019 g/mol |
| Monoisotopic Mass | 504.1462019 g/mol |
| Topological Polar Surface Area | 174 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 658 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 12 | |
|---|---|
| Drug Name | Cleocin phosphate |
| Drug Label | CLEOCIN PHOSPHATE Sterile Solution in vials contains clindamycin phosphate, a water soluble ester of clindamycin and phosphoric acid. Each mL contains the equivalent of 150 mg clindamycin, 0.5 mg disodium edetate and 9.45 mg benzyl alcohol added as p... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 150mg base/ml |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 2 of 12 | |
|---|---|
| Drug Name | Cleocin t |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel; Lotion; Solution |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 3 of 12 | |
|---|---|
| Drug Name | Clindagel |
| Drug Label | Clindagel (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene g... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Precision Dermat |
| 4 of 12 | |
|---|---|
| Drug Name | Clindamycin phosphate |
| PubMed Health | Clindamycin (Injection) |
| Drug Classes | Antibiotic, Antimalarial |
| Drug Label | Clindamycin Injection, USP, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH is 6.5 range 5.5to 7.0.Clin... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Lotion; Gel; Swab; Injectable; Cream; Aerosol, foam; Solution |
| Route | Topical; Injection; Vaginal |
| Strength | eq 1% base; 1%; eq 150mg base/ml; eq 2% base |
| Market Status | Prescription |
| Company | Wockhardt; Sagent Strides; Bedford; Fougera Pharms; Fresenius Kabi Usa; Hospira; Hikma Maple; Versapharm; Perrigo Uk Finco; Perrigo New York; Taro Pharm Inds; Fougera; G And W Labs |
| 5 of 12 | |
|---|---|
| Drug Name | Clindesse |
| Drug Label | CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Cream |
| Route | Vaginal |
| Strength | eq 2% base |
| Market Status | Prescription |
| Company | Lumara Health |
| 6 of 12 | |
|---|---|
| Drug Name | Clindets |
| Drug Label | Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is meth... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Swab |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Perrigo |
| 7 of 12 | |
|---|---|
| Drug Name | Cleocin phosphate |
| Drug Label | CLEOCIN PHOSPHATE Sterile Solution in vials contains clindamycin phosphate, a water soluble ester of clindamycin and phosphoric acid. Each mL contains the equivalent of 150 mg clindamycin, 0.5 mg disodium edetate and 9.45 mg benzyl alcohol added as p... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 150mg base/ml |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 8 of 12 | |
|---|---|
| Drug Name | Cleocin t |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel; Lotion; Solution |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 9 of 12 | |
|---|---|
| Drug Name | Clindagel |
| Drug Label | Clindagel (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene g... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Precision Dermat |
| 10 of 12 | |
|---|---|
| Drug Name | Clindamycin phosphate |
| PubMed Health | Clindamycin (Injection) |
| Drug Classes | Antibiotic, Antimalarial |
| Drug Label | Clindamycin Injection, USP, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH is 6.5 range 5.5to 7.0.Clin... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Lotion; Gel; Swab; Injectable; Cream; Aerosol, foam; Solution |
| Route | Topical; Injection; Vaginal |
| Strength | eq 1% base; 1%; eq 150mg base/ml; eq 2% base |
| Market Status | Prescription |
| Company | Wockhardt; Sagent Strides; Bedford; Fougera Pharms; Fresenius Kabi Usa; Hospira; Hikma Maple; Versapharm; Perrigo Uk Finco; Perrigo New York; Taro Pharm Inds; Fougera; G And W Labs |
| 11 of 12 | |
|---|---|
| Drug Name | Clindesse |
| Drug Label | CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Cream |
| Route | Vaginal |
| Strength | eq 2% base |
| Market Status | Prescription |
| Company | Lumara Health |
| 12 of 12 | |
|---|---|
| Drug Name | Clindets |
| Drug Label | Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is meth... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Swab |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Perrigo |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13725
Submission : 1998-09-01
Status : Inactive
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13705
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7359
Submission : 1988-02-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13499
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13413
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-06
Pay. Date : 2014-02-26
DMF Number : 12922
Submission : 1998-04-02
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-12
Pay. Date : 2013-01-23
DMF Number : 14412
Submission : 1999-09-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13082
Submission : 1998-07-08
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Clindamycin Phosphate, Albano Plant
Certificate Number : R1-CEP 2006-033 - Rev 04
Status : Valid
Issue Date : 2022-09-01
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 1999-025 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2007-06-15
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2005-033 - Rev 03
Status : Valid
Issue Date : 2023-01-17
Type : Chemical
Substance Number : 996
Clindamycin Phosphate, Alternative Process
Certificate Number : R1-CEP 2009-398 - Rev 04
Status : Valid
Issue Date : 2022-11-08
Type : Chemical
Substance Number : 996
Certificate Number : CEP 2022-145 - Rev 00
Status : Valid
Issue Date : 2024-05-27
Type : Chemical
Substance Number : 996
Certificate Number : R0-CEP 2007-250 - Rev 01
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2009-07-07
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2000-097 - Rev 05
Status : Valid
Issue Date : 2023-06-09
Type : Chemical
Substance Number : 996
Clindamycin Phosphate, Product Code Number 60960
Certificate Number : R0-CEP 2003-177 - Rev 01
Status : Expired
Issue Date : 2010-01-14
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2000-256 - Rev 05
Status : Withdrawn by Holder
Issue Date : 2019-01-31
Type : Chemical
Substance Number : 996
Certificate Number : R0-CEP 2007-299 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2012-03-08
Type : Chemical
Substance Number : 996
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - EQ 300MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - SOLUTION;INTRAVENOUS - EQ 600MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - SOLUTION;INTRAVENOUS - EQ 900MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - INJECTABLE;INJECTION - EQ 150MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 150MG BASE/ML
USFDA APPLICATION NUMBER - 50441
DOSAGE - SOLUTION;TOPICAL - EQ 1% BASE **Fede...DOSAGE - SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50537
DOSAGE - LOTION;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50600
DOSAGE - GEL;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50615
DOSAGE - GEL;TOPICAL - 5%;1.2%
USFDA APPLICATION NUMBER - 50741
DOSAGE - GEL;TOPICAL - 5%;EQ 1% BASE
USFDA APPLICATION NUMBER - 50756
DOSAGE - SUPPOSITORY;VAGINAL - 100MG
USFDA APPLICATION NUMBER - 50767
DOSAGE - GEL;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50782
DOSAGE - CREAM;VAGINAL - EQ 2% BASE
USFDA APPLICATION NUMBER - 50793
DOSAGE - AEROSOL, FOAM;TOPICAL - 1% **Federal...DOSAGE - AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50801
DOSAGE - GEL;TOPICAL - 1.2%;0.025%
USFDA APPLICATION NUMBER - 50803
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]BioSpectra
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Solubilizers
Thickeners and Stabilizers
Parenteral
Film Formers & Plasticizers
Emulsifying Agents
Fillers, Diluents & Binders
Coating Systems & Additives
Surfactant & Foaming Agents
Co-Processed Excipients
Direct Compression
Controlled & Modified Release
Rheology Modifiers
Lubricants & Glidants
Taste Masking
Granulation
API Stability Enhancers
Chewable & Orodispersible Aids
Soft Gelatin
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
Company :
Clindamycin Phosphate
Drug Cost (USD) : 14,706
Year : 2022
Prescribers : 79
Prescriptions : 134
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin Phosphate
Drug Cost (USD) : 408,784
Year : 2022
Prescribers : 66
Prescriptions : 154
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin Phosphate
Drug Cost (USD) : 53,595
Year : 2022
Prescribers : 212
Prescriptions : 289
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin/Tretinoin
Drug Cost (USD) : 7,997
Year : 2022
Prescribers :
Prescriptions : 15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin Phosphate
Drug Cost (USD) : 12,291
Year : 2021
Prescribers : 60
Prescriptions : 105
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin Phosphate
Drug Cost (USD) : 537,624
Year : 2021
Prescribers : 110
Prescriptions : 243
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin Phosphate
Drug Cost (USD) : 66,495
Year : 2021
Prescribers : 225
Prescriptions : 322
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin/Tretinoin
Drug Cost (USD) : 6,168
Year : 2021
Prescribers :
Prescriptions : 11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin/Tretinoin
Drug Cost (USD) : 5,200
Year : 2021
Prescribers :
Prescriptions : 11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Clindamycin Phosphate
Drug Cost (USD) : 72,016
Year : 2020
Prescribers : 249
Prescriptions : 329
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Clindamycin Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clindamycin Phosphate manufacturer or Clindamycin Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clindamycin Phosphate manufacturer or Clindamycin Phosphate supplier.
PharmaCompass also assists you with knowing the Clindamycin Phosphate API Price utilized in the formulation of products. Clindamycin Phosphate API Price is not always fixed or binding as the Clindamycin Phosphate Price is obtained through a variety of data sources. The Clindamycin Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EVOCLIN manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EVOCLIN, including repackagers and relabelers. The FDA regulates EVOCLIN manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EVOCLIN API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of EVOCLIN manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A EVOCLIN supplier is an individual or a company that provides EVOCLIN active pharmaceutical ingredient (API) or EVOCLIN finished formulations upon request. The EVOCLIN suppliers may include EVOCLIN API manufacturers, exporters, distributors and traders.
click here to find a list of EVOCLIN suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A EVOCLIN DMF (Drug Master File) is a document detailing the whole manufacturing process of EVOCLIN active pharmaceutical ingredient (API) in detail. Different forms of EVOCLIN DMFs exist exist since differing nations have different regulations, such as EVOCLIN USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A EVOCLIN DMF submitted to regulatory agencies in the US is known as a USDMF. EVOCLIN USDMF includes data on EVOCLIN's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The EVOCLIN USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of EVOCLIN suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The EVOCLIN Drug Master File in Japan (EVOCLIN JDMF) empowers EVOCLIN API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the EVOCLIN JDMF during the approval evaluation for pharmaceutical products. At the time of EVOCLIN JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of EVOCLIN suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a EVOCLIN Drug Master File in Korea (EVOCLIN KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of EVOCLIN. The MFDS reviews the EVOCLIN KDMF as part of the drug registration process and uses the information provided in the EVOCLIN KDMF to evaluate the safety and efficacy of the drug.
After submitting a EVOCLIN KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their EVOCLIN API can apply through the Korea Drug Master File (KDMF).
click here to find a list of EVOCLIN suppliers with KDMF on PharmaCompass.
A EVOCLIN CEP of the European Pharmacopoeia monograph is often referred to as a EVOCLIN Certificate of Suitability (COS). The purpose of a EVOCLIN CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of EVOCLIN EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of EVOCLIN to their clients by showing that a EVOCLIN CEP has been issued for it. The manufacturer submits a EVOCLIN CEP (COS) as part of the market authorization procedure, and it takes on the role of a EVOCLIN CEP holder for the record. Additionally, the data presented in the EVOCLIN CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the EVOCLIN DMF.
A EVOCLIN CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. EVOCLIN CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of EVOCLIN suppliers with CEP (COS) on PharmaCompass.
A EVOCLIN written confirmation (EVOCLIN WC) is an official document issued by a regulatory agency to a EVOCLIN manufacturer, verifying that the manufacturing facility of a EVOCLIN active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting EVOCLIN APIs or EVOCLIN finished pharmaceutical products to another nation, regulatory agencies frequently require a EVOCLIN WC (written confirmation) as part of the regulatory process.
click here to find a list of EVOCLIN suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing EVOCLIN as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for EVOCLIN API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture EVOCLIN as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain EVOCLIN and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a EVOCLIN NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of EVOCLIN suppliers with NDC on PharmaCompass.
EVOCLIN Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EVOCLIN GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EVOCLIN GMP manufacturer or EVOCLIN GMP API supplier for your needs.
A EVOCLIN CoA (Certificate of Analysis) is a formal document that attests to EVOCLIN's compliance with EVOCLIN specifications and serves as a tool for batch-level quality control.
EVOCLIN CoA mostly includes findings from lab analyses of a specific batch. For each EVOCLIN CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EVOCLIN may be tested according to a variety of international standards, such as European Pharmacopoeia (EVOCLIN EP), EVOCLIN JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EVOCLIN USP).
